Correlation Between Atreca and Cullinan Oncology
Can any of the company-specific risk be diversified away by investing in both Atreca and Cullinan Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Atreca and Cullinan Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Atreca Inc and Cullinan Oncology LLC, you can compare the effects of market volatilities on Atreca and Cullinan Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Atreca with a short position of Cullinan Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Atreca and Cullinan Oncology.
Diversification Opportunities for Atreca and Cullinan Oncology
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Atreca and Cullinan is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Atreca Inc and Cullinan Oncology LLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cullinan Oncology LLC and Atreca is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Atreca Inc are associated (or correlated) with Cullinan Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cullinan Oncology LLC has no effect on the direction of Atreca i.e., Atreca and Cullinan Oncology go up and down completely randomly.
Pair Corralation between Atreca and Cullinan Oncology
If you would invest (100.00) in Atreca Inc on December 29, 2024 and sell it today you would earn a total of 100.00 from holding Atreca Inc or generate -100.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Atreca Inc vs. Cullinan Oncology LLC
Performance |
Timeline |
Atreca Inc |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Cullinan Oncology LLC |
Atreca and Cullinan Oncology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Atreca and Cullinan Oncology
The main advantage of trading using opposite Atreca and Cullinan Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Atreca position performs unexpectedly, Cullinan Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cullinan Oncology will offset losses from the drop in Cullinan Oncology's long position.Atreca vs. Passage Bio | Atreca vs. Stoke Therapeutics | Atreca vs. Revolution Medicines | Atreca vs. Black Diamond Therapeutics |
Cullinan Oncology vs. Bolt Biotherapeutics | Cullinan Oncology vs. Day One Biopharmaceuticals | Cullinan Oncology vs. Lyra Therapeutics | Cullinan Oncology vs. Autolus Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Complementary Tools
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |